SPE Clause Samples
The SPE (Special Purpose Entity) clause defines the creation or use of a separate legal entity established for a specific, limited business purpose, often to isolate financial risk or facilitate a particular transaction. In practice, this clause outlines the requirements for forming the SPE, such as its ownership structure, operational restrictions, and the scope of its permitted activities. By clearly delineating the role and limitations of the SPE, the clause helps ensure that liabilities and risks associated with certain projects or assets are segregated from the parent company, thereby protecting the parent’s financial health and providing clarity to all parties involved.
POPULAR SAMPLE Copied 1 times
SPE. If Borrower fails to maintain its status as a Special Purpose Entity, breaches any representation or fails to comply with any warranty or covenant set forth in Section 4.1.30 hereof;
SPE. Any special purpose Affiliate of HPSC.
SPE. Lessor is and has at all times since its formation been a Special Purpose Bankruptcy Remote Entity.
SPE. Lessor shall at all times be a Special Purpose Bankruptcy Remote Entity.
SPE. Manager agrees that it shall not perform its duties under the Management Agreement or otherwise act in a manner that would result in Borrower's failure to be a "Special Purpose Bankruptcy Remote Entity" as defined in the Loan Agreement (a copy of which definition has been received by Manager).
SPE. “incur” (and derivatives thereof) means to, directly or indirectly, create, incur, assume, issue, guarantee, extend the maturity of, or otherwise become liable with respect to any Indebtedness; provided, however, that neither the accrual of interest (whether such interest is payable in cash or kind) nor the accretion of original issue discount shall be considered an incurrence of Indebtedness.
SPE. Skills Performance Evaluation.
SPE. No SPE shall engage in any activity or conduct any business other than a Mortgage Transaction.
SPE. In addition, for purposes of determining if actions are permitted under this Agreement if such actions are premised on compliance with certain specified financial statement ratios or tests, such determinations shall be made taking into account the elimination for accounting purposes of each Special Film Entity, each Specified JV and the Real Property SPE.
SPE. The crude product was taken up in 0.5 ml H2O and applied to a small column containing fluoroflashTM fluorous silica (4g) which was preeluted with H2O. The column was eluted with H2O and 10% CH3CN in H2O until all the non-fluorous by-products were removed. The fluorous product was then eluted from the column with a 2/2/1 mixture of acetony/CH3CN/H2O. Lyophilization gave the partially protected oligomer of which the integrity and purity was confirmed by LC-MS, HRMS and NMR (1H, 13C, 31P) analysis. RP-HPLC: ▇▇▇▇▇▇ preparative HPLC system; column: Alltima C18 or C4, particle size: 5 μm, dimensions: 10/250 mm; eluent: (10 mM NH4OAc in H2O for C18 or 25mM TEAA for in H2O for C4)/MeCN, 9/1 → 1/9, detection: UV (215 and 254 nm), the fractions containing product were collected and the solvents were removed under reduced pressure. Repeated lyophilization (▇▇▇▇▇) of the residue gave the partially protected oligomer of which the integrity and purity was confirmed by LC-MS, HRMS and NMR (1H, 13C, 31P) analysis. 4-(2-perfluorooctylethyl)benzyl N-(6-hydroxyhexyl)carbamate (16) To a cooled (0 oC) solution of fluorous benzyl alcohol 15 (1.11 g, 2.00 mmol) in THF (20 ml) was added phosgene (2M in toluene, 2.50 ml, 5 mmol). After stirring for 90 minutes the volatiles were removed under reduced pressure and the residue coevaporated with THF (10 ml). The crude chloroformate was dissolved in a mixture of THF (30 ml) and sat. aq. NaHCO3 (12 ml) after which 1-amino-6-hexanol (2.34 g, 20 mmol) was added. After stirring overnight the mixture was diluted with Et2O (300 ml) and washed with brine (2 x 150 ml). The organic layer was dried (Na2SO4) and concentrated in vacuo. Crystallization (EtOAc/PE) of the residue afforded the title carbamate (16, 1.21 g, 1.74 mmol, 87%) as an amorphous off-white solid. 1H NMR (300 MHz): δ = 1.30 - 1.41 (m, 4H, 2 x CH2 hexylspacer), 1.47 - 1.60 (m, 4H, 2 x CH2 hexylspacer), 2.27 - 2.48 (m, 2H, F17C8CH2CH2-), 2.86 - 2.98 (m, 2H, F17C8CH2CH2-), 3.11 - 3.21 (m, 2H, CH2-N hexylspacer), 3.58 (t, 2H, J = 6.5 Hz, CH2-O hexylspacer), 5.06 (s, 2H, CH2 F-Bn), 5.41 (bs, 1H, NH), 7.22 (d, 2H, J = 7.8 Hz, Harom), 7.32 (d, 2H, J = 7.9 Hz, Harom); 13C NMR (75 MHz): δ = 25.1, 25.9, 26.2 (2 x CH2 hexylspacer, F17C8CH2CH2-), 29.6, 32.1 (2 x CH2 hexylspacer), 32.7 (t, J = 22 Hz, F17C8CH2CH2-), 40.7 (CH2-N hexylspacer), 61.9 (CH2-O hexylspacer), 66.1 (CH2 F-Bn), 128.3 - 128.4 (CHarom), 134.9 (Cq F-Bn), 138.9 (Cq F-Bn). 4-(2-perfluorooctylethyl)benzyl N-(6-O-[{N,N-diisopr...